Encysive Pharmaceuticals Completes $60 Million Note Offering Secured by Argatroban Royalties
06 févr. 2007 16h05 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that its newly formed, wholly-owned subsidiary has closed a private placement of $60 million in...
Encysive Pharmaceuticals Announces Presentation/Webcast At BIO CEO Conference
05 févr. 2007 16h35 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Feb. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 9th Annual BIO CEO & Investor Conference, taking place February...
Encysive Pharmaceuticals Announces Conference Call to Discuss Fourth Quarter and Year End 2006 Results
30 janv. 2007 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 30, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) will hold an investor conference call on Friday, March 9, 2007 at 8:00 a.m. ET to discuss its fourth quarter and year...
Encysive Pharmaceuticals Announces Presentation/Webcast At 25th Annual JPMorgan Healthcare Conference
04 janv. 2007 08h00 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Jan. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it will participate in the 25th Annual JPMorgan Healthcare Conference, taking place January 8-11,...
FDA Accepts Encysive's Complete Response to THELIN New Drug Application
28 déc. 2006 13h53 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 28, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's complete...
Encysive Pharmaceuticals Announces Launch of Thelin in Germany
18 déc. 2006 02h30 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 18, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that THELIN(r)(1) (sitaxentan sodium(2)) 100 mg tablets are now commercially available in Germany for...
Encysive Pharmaceuticals' THELIN (sitaxentan sodium) Receives Positive Opinion From Australian Health Authority
15 déc. 2006 13h47 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 15, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Australian Drug Evaluation Committee (ADEC) of the Therapeutic Goods Administration (TGA)...
Encysive Pharmaceuticals Submits Response to FDA For Thelin New Drug Application
14 déc. 2006 21h03 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced it has provided the information requested by the U.S. Food and Drug Administration (FDA) in its letter...
Encysive Expects to Submit Revised Response to Thelin Approvable Letter Within Several Days
14 déc. 2006 08h35 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 14, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) announced today that the U.S. Food and Drug Administration (FDA) informed the Company that its response to the...
Encysive Pharmaceuticals Receives FDA Clearance to Resume Clinical Studies With TBC3711
07 déc. 2006 18h45 HE
|
Encysive Pharmaceuticals Inc.
HOUSTON, Dec. 7, 2006 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that it has received clearance from the U.S. Food and Drug Administration (FDA) to initiate and resume...